United States · FDA National Drug Code directory
Insulin Aspart
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73070-100_18e1bdfe-0180-4988-9797-5ee4660e3840
- Product NDC
- 73070-100
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin aspart
- Labeler
- Novo Nordisk Pharma, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20010827 / 20271231
Source-listed ingredients
- INSULIN ASPART — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (73070-100-11) / 10 mL in 1 VIAL, GLASS · 73070-100-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →